| Biomarker ID | 1241 |
| PMID | 24211598 |
| Year | 2014 |
| Biomarker | PCA3 /PSA ratio (PCa antigen 3 [PCA3]) |
| Biomarker Basis | Expression Based |
| Biomolecule | mRNA |
| Source | Urine |
| Subjects | Humans |
| Regulation | Upregulated in PCa |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | NA |
| Experiment | Prostate Cancer Vs No Prostate Cancer |
| Type of Biomarker | Diagnostic |
| Cohort | A total of 30 patients were included in study, from whom a total of 60 urinary samples were collected. For analysis we used a urinary sample obtained before and after DRE from each patient. |
| Senstivity | NA |
| Specificity | NA |
| AUC | 0.673 (95% CI: 0.45-0.89) |
| Accuracy | NA |
| Level Of Significance | NA |
| Method Used | RT-PCR |
| Clinical | No |
| Remarks | AUC Values for PCA3 Cell Pellet - After Digital Rectal Exam (DRE) |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | NA |